✦ LIBER ✦

Quality of life and treatment outcomes : Prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

✍ Scribed by Cheryl L. Shrader-Bogen; Janice L. Kjellberg; Carol P. McPherson; Charles L. Murray

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 169 KB
Volume: 79
Category: Article
ISSN: 0008-543X
DOI: 10.1002/(sici)1097-0142(19970515)79:10<1977::aid-cncr20>3.0.co;2-r

No coin nor oath required. For personal study only.

✦ Synopsis

prostate carcinoma on overall QOL in the two treatment groups. The PCTO-Q of Minnesota Medical School, Minneapolis, assessed the patients' perceptions of the incidence and severity of specific changes Minnesota.

in bowel, urinary, and sexual functions. The test-retest reliability of the PCTO-Q in a pilot study was 91.2%.

RESULTS.

Two hundred seventy-four eligible men completed the questionnaires; 132 (48%) reported having undergone prostatectomy and 142 (52%) reported having undergone radiotherapy. After age adjustment, the radiotherapy group reported more bowel dysfunction (P Å 0.001), whereas the prostatectomy group reported more urinary problems (P Å 0.03) and more sexual dysfunction (P Å 0.001). Scores for the FACT-G were similar in the two treatment groups.

CONCLUSIONS.

Men undergoing treatment for clinically localized prostate carcinoma continue to experience difficulty long after treatment. In this study, the prostatectomy group fared worse in regard to sexual and urinary functions, whereas the radiotherapy group experienced more bowel dysfunction. Survivor-reported Presented in part at the American Cancer Society National Conference on Cancer Nursing Re-QOL and treatment outcomes can assist physicians in counseling patients in the search,

📜 SIMILAR VOLUMES

Assessment of outcome prediction models

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy

✍ Anthony V. D'Amico; April Desjardin; Arnold Chung; Ming-Hui Chen; Delray Schultz 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho

Pathologic seminal vesicle invasion afte

Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma : Effect of early adjuvant radiation therapy on biochemical control

✍ Richard K. Valicenti; Leonard G. Gomella; Mohammed Ismail; S. Grant Mullholland; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: The authors evaluated the effect of postoperative radiation therapy on freedom from biochemical failure (bned) in men with prostate carcinoma who had pathologic seminal vesicle invasion after radical prostatectomy and negative pelvic lymph node dissection (pt3cn0). ## Methods: Betw

Calculated prostate carcinoma volume : T

Calculated prostate carcinoma volume : The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter

✍ Anthony V. D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Background: In this study, the authors evaluated whether a clinically relevant stratification of prostate specific antigen (psa) failure free survival (bned) after definitive local therapy could be made for patients with prostate carcinoma clinically classified as t1 or t2 and pretreatment psa l